Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-456
Closed -$52.4K 4138
2026
Q1
$52.4K Buy
456
+122
+37% +$10.8K ﹤0.01% 2144
2025
Q4
$21.8K Sell
334
-36
-10% -$2.87K ﹤0.01% 2560
2025
Q3
$30.4K Buy
370
+67
+22% +$4.82K ﹤0.01% 2297
2025
Q2
$20K Sell
303
-191
-39% -$11.9K ﹤0.01% 2462
2025
Q1
$32.4K Buy
494
+252
+104% +$17.1K ﹤0.01% 2102
2024
Q4
$18.6K Buy
242
+10
+4% +$864 ﹤0.01% 2300
2024
Q3
$19.4K Buy
232
+97
+72% +$6.46K ﹤0.01% 2126
2024
Q2
$7.45K Sell
135
-17
-11% -$924 ﹤0.01% 2393
2024
Q1
$10.6K Buy
152
+37
+32% +$2.35K ﹤0.01% 2037
2023
Q4
$7.11K Buy
+115
New +$5.19K ﹤0.01% 2070

Other funds holding ACLX

GAMMA Investing's ACLX Position: Q2 2026 in Review

GAMMA Investing sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 456 shares — an estimated $52.4K sold.

GAMMA Investing first reported a position in ACLX in Q4 2023 and held it in 10 quarters. The position peaked at $52.4K in Q1 2026. 1 fund tracked by Wall St. Rank holds ACLX as of Q2 2026.

  • GAMMA Investing reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 456 Arcellx shares in Q2 2026, an estimated $52.4K.
  • GAMMA Investing first reported a position in Arcellx in Q4 2023 and held it in 10 quarters.
  • GAMMA Investing's Arcellx position peaked at $52.4K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.